1. Главная
  2. Ресурсы
  3. Библиотечный поиск
The Impact OfSuccinateDehydrogenase Gene(SDH) Mutations InRenal Cell Carcinoma(RCC): A SystematicReview Seyed Mohammad Kazem AghamirRamin HeshmatMehdi Ebrahimi2019 год

<p>The Impact Of <em>Succinate Dehydrogenase</em> Gene (SDH) Mutations In Renal Cell Carcinoma (RCC): A Systematic Review</p>
статья из журнала

Полный текстСтраница публикацииПубликация в OpenAlex
Аннотация: Introduction: Renal cell cancer (RCC) syndrome is linked to Krebs cycle compartments and their coding genes' alterations like succinate dehydrogenase genes ( SDHx ). Here we present a systematic review of the SDH genes' mutations and their impact on both RCC diagnosis and prognosis. Methods: This systematic review includes any study in which tissue samples of RCC are considered in correlation with the SDHx mutations, microsatellite instability (MSI), and protein expression. For this purpose, a systematic search of MEDLINE (PubMed), Scopus, Embase, and Web of Science databases was conducted and finally 5384 articles were recruited. All studies' content was checked to find the related ones which were 145 articles, which with data extraction were limited to nineteen. Results: The final selected nineteen studies investigating the SDHx role in RCC tumor genesis were included, among which fifteen were mutation analysis, three were just SDHx protein expression, and two were MSI and mutation analysis studies. A total of 432 RCC patients were reported by SDH mutations, and 64 patients with MSI and SDH expression change were reported in 514 surgically resected renal epithelial tumors. The most common mutation was the single nucleotide variant rs772551056 (c.137G>A) of SDHB . For SDHC , c.380A>G presented in 48 RCC patients, and for SDHA a novel germline mutation c.2T>C: p.M1T in an occasional case of gastrointestinal stromal tumor intricate with RCC. Conclusion: RCC as an aggressive type of kidney cancer needs some biomarkers to be diagnosed exactly. It was shown recently that the succinate dehydrogenase gene variations can provide this diagnostic and prognostic biomarker. For this purpose, SDHB rs772551056 associated with its protein expression alterations can be taken into account. It is possible that a novel mutation of SDHA (c.2T>C: p.M1T) can provide evidence of GIST associated with RCC as well. Keywords: renal cell cancer, RCC, succinate dehydrogenases, mutation, expression, MSI
Год издания: 2019
Авторы: Seyed Mohammad Kazem Aghamir, Ramin Heshmat, Mehdi Ebrahimi, Seyed Ebrahim Ketabchi, Somayeh Parichehreh-Dizaji, Fatemeh Khatami
Издательство: Dove Medical Press
Источник: OncoTargets and Therapy
Ключевые слова: Renal cell carcinoma treatment, Cancer, Hypoxia, and Metabolism, Renal and related cancers
Другие ссылки: OncoTargets and Therapy (PDF)
OncoTargets and Therapy (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
PubMed (HTML)